Skip to main content
. 2021 May 22;61(4):1023–1031. doi: 10.47162/RJME.61.4.04

Table 3.

The usefulness of hepatic fibrosis scoring systems in pediatric patients diagnosed with NAFLD

Hepatic fibrosis score

Parameters used

Accuracy in pediatric patients

AST/ALT ratio

AST, ALT

Very low [6, 9]

APRI

AST, platelets

High [9]

Forns index

Total bilirubin, GGT, α2-macroglobulin, apolipoprotein A1, haptoglobin.

Moderate [9]

FIB-4 score

Age, AST, ALT, platelets

High accuracy in differentiating significant from mild fibrosis [9].

ELF test

HA, PIIINP, TIMP-1

Good accuracy for differentiating significant fibrosis (stage 3) from mild or no fibrosis (AUROC=0.99, 10.51 cutoff) [4].

PNFI

Age, waist circumference, triglyceride level.

Good accuracy for differentiating hepatic fibrosis from no fibrosis (AUROC=0.85, 0.76 respectively) [3, 10].

PNFI + ELF test

Excellent accuracy for the prediction of hepatic fibrosis (AUROC=0.94) [3].

ALT: Alanine aminotransferase; APRI: AST to platelet ratio index; AST: Aspartate aminotransferase; AUROC: Area under the receiver operating characteristics curve; ELF: Enhanced liver fibrosis; FIB-4: Fibrosis-4; GGT: Gamma-glutamyl transferase; HA: Hyaluronic acid; NAFLD: Non-alcoholic fatty liver disease; PIIINP: Procollagen III N-terminal peptide; TIMP-1: Tissue inhibitor of metalloproteinase-1; PNFI: Pediatric NAFLD fibrosis index